F1 Pharma S.A. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: Department Stores | Engineering Services | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services

Full name: F1 Pharma S.A.

Profile Updated: June 17, 2025

F1 Pharma S.A. is based in Poland. The head office is in Krakow. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on August 06, 2019. The latest financial highlights indicate a net sales revenue increase of 22.65% in 2025. Its’ total assets recorded a growth of 2.96%.

Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the F1 Pharma S.A. report to view the information.

Website: http://www.f1pharma.pl

Basic Information

Registered Capital:

Purchase the F1 Pharma S.A. report to view the information.

Financial Auditors:

Purchase the F1 Pharma S.A. report to view the information.

Incorporation Date:

August 06, 2019

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Supervisory Board Member

Purchase this report to view the information.

Supervisory Board Member

Company Performance

Financial values in the chart are available after F1 Pharma S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

22.65%▲

Total Operating Revenue

3.3%▲

Operating Profit

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

2.96%▲

Total Equity

76.69%▲

Operating Profit Margin

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Quick Ratio

0.38%▲

Cash Ratio

-0.04%▼

Similar companies